Cosopt sine Augndropar, lausn 20 mg/ml+5 mg/ml Islândia - islandês - LYFJASTOFNUN (Icelandic Medicines Agency)

cosopt sine augndropar, lausn 20 mg/ml+5 mg/ml

santen oy* - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20 mg/ml+5 mg/ml

Dorzolamide/Timolol Alvogen Augndropar, lausn 20mg/ml+5 mg/ml Islândia - islandês - LYFJASTOFNUN (Icelandic Medicines Agency)

dorzolamide/timolol alvogen augndropar, lausn 20mg/ml+5 mg/ml

alvogen ehf. - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20mg/ml+5 mg/ml

DUOKOPT (JOZ) Augndropar, lausn 20 mg/ml + 5 mg/ml Islândia - islandês - LYFJASTOFNUN (Icelandic Medicines Agency)

duokopt (joz) augndropar, lausn 20 mg/ml + 5 mg/ml

laboratoires thea s.a.s. - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20 mg/ml + 5 mg/ml

Intuniv União Europeia - islandês - EMA (European Medicines Agency)

intuniv

takeda pharmaceuticals international ag ireland branch - guanfacín hýdróklóríð - attention deficit disorder með ofvirkni - antiadrenergic agents, centrally acting, antihypertensives, - intuniv is indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children and adolescents 6 17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective. intuniv verður að vera notað sem hluti af alhliða kynlÍf meðferð áætlun, venjulega þar á meðal sálfræðilega, mennta og félagslega mælist.

Narcostop Stungulyf, lausn 5 mg/ml Islândia - islandês - LYFJASTOFNUN (Icelandic Medicines Agency)

narcostop stungulyf, lausn 5 mg/ml

le vet b.v.* - atipamezolum hýdróklóríð - stungulyf, lausn - 5 mg/ml